Hereditary & GI Cancer Marker Panel (BRCA1/2 + CA 19-9)
🧬 Advanced Oncology Panel
₹25999
MRP ₹28000
Sample Cut-off: 4:30 PM
Report: 15-21 Working Days (Due to genetic analysis)
Sample Type: Blood (EDTA & Serum)
Test Code: BC305 (Assigned)
Report: 15-21 Working Days (Due to genetic analysis)
Sample Type: Blood (EDTA & Serum)
Test Code: BC305 (Assigned)
Important Instructions:
• Fasting is not required for this panel, but please inform the lab of any medications you are taking.
• This is a specialized test that requires a single blood draw from which our laboratory will separate the different components needed for genetic and protein analysis.
• Fasting is not required for this panel, but please inform the lab of any medications you are taking.
• This is a specialized test that requires a single blood draw from which our laboratory will separate the different components needed for genetic and protein analysis.
About this Package:
The Hereditary & GI Cancer Marker Panel is an advanced profile from our diagnostic center that combines two crucial areas of cancer risk assessment. It includes BRCA1 & BRCA2 gene analysis to assess your lifetime hereditary risk for certain cancers, and the CA 19-9 tumor marker test, which is associated with gastrointestinal cancers.
✔ BRCA 1/2 Analysis identifies inherited mutations that significantly increase the risk of Breast, Ovarian, Prostate, and Pancreatic Cancer.
✔ CA 19-9 is a tumor marker used to monitor and assess Pancreatic Cancer, as well as other GI cancers (e.g., gallbladder, bile duct).
✔ This panel is intended for individuals with a strong personal or family history of these specific cancers.
The Hereditary & GI Cancer Marker Panel is an advanced profile from our diagnostic center that combines two crucial areas of cancer risk assessment. It includes BRCA1 & BRCA2 gene analysis to assess your lifetime hereditary risk for certain cancers, and the CA 19-9 tumor marker test, which is associated with gastrointestinal cancers.
✔ BRCA 1/2 Analysis identifies inherited mutations that significantly increase the risk of Breast, Ovarian, Prostate, and Pancreatic Cancer.
✔ CA 19-9 is a tumor marker used to monitor and assess Pancreatic Cancer, as well as other GI cancers (e.g., gallbladder, bile duct).
✔ This panel is intended for individuals with a strong personal or family history of these specific cancers.
Tests Included in This Panel
This panel provides a dual assessment: your genetic predisposition and a current snapshot of a key protein marker.
- BRCA1 & BRCA2 Gene Analysis:
This is a genetic (DNA) test that reads the entire code of your BRCA1 and BRCA2 genes. These are tumor suppressor genes. If you inherit a harmful mutation (error) in one of these genes, their ability to repair damaged DNA is lost. This doesn't mean you have cancer, but it significantly increases your lifetime risk of developing certain cancers, including breast, ovarian, prostate, and, notably, pancreatic cancer. - Cancer Antigen 19-9 (CA 19-9):
This is a tumor marker test, not a genetic test. It measures the level of a protein called CA 19-9 in your blood. This test is not a general screening tool for cancer, as levels can also be elevated in benign conditions (like pancreatitis or bile duct obstruction). However, it is a crucial test used by doctors to help monitor the treatment of diagnosed pancreatic cancer and is sometimes used as part of a high-risk screening protocol in individuals with a high genetic risk (like a BRCA mutation).
Why Combine These Tests?
The common link between these two tests is pancreatic cancer. Individuals with a BRCA1 or BRCA2 mutation have a known higher risk of developing pancreatic cancer. The CA 19-9 test is the primary blood marker used in its management. This panel is therefore designed for high-risk individuals and their families to provide a more complete picture of both genetic risk (BRCA) and current marker status (CA 19-9).
Frequently Asked Questions (FAQ)
Q1: What is the main purpose of this panel?
This is a specialized oncology panel for high-risk individuals. It combines a genetic test (BRCA1/2) to understand your inherited risk for cancers (like breast, ovarian, pancreatic) with a tumor marker test (CA 19-9) associated with gastrointestinal cancers, especially pancreatic.
This is a specialized oncology panel for high-risk individuals. It combines a genetic test (BRCA1/2) to understand your inherited risk for cancers (like breast, ovarian, pancreatic) with a tumor marker test (CA 19-9) associated with gastrointestinal cancers, especially pancreatic.
Q2: If my BRCA test is positive, will my CA 19-9 be high?
Not necessarily. A positive BRCA test means you have a high risk of developing certain cancers. A high CA 19-9 is a marker often associated with the presence of a tumor. They measure two different things: risk vs. a current biological signal.
Not necessarily. A positive BRCA test means you have a high risk of developing certain cancers. A high CA 19-9 is a marker often associated with the presence of a tumor. They measure two different things: risk vs. a current biological signal.
Q3: Is the CA 19-9 test a screening test for cancer?
No, CA 19-9 is not recommended as a screening test for the general, asymptomatic population because it can be elevated in many non-cancerous conditions. It is primarily used to monitor patients already diagnosed with cancer or for screening in very high-risk individuals (e.g., those with a BRCA mutation).
No, CA 19-9 is not recommended as a screening test for the general, asymptomatic population because it can be elevated in many non-cancerous conditions. It is primarily used to monitor patients already diagnosed with cancer or for screening in very high-risk individuals (e.g., those with a BRCA mutation).
Q4: Why does the report take 15-21 working days?
The CA 19-9 test is fast (often same-day). However, the BRCA1 & BRCA2 analysis is a complex, high-level genetic sequencing test. It involves extracting your DNA, sequencing the entire genes, and having a geneticist analyze the data for any mutations. This advanced process at our laboratory takes time to ensure accuracy.
The CA 19-9 test is fast (often same-day). However, the BRCA1 & BRCA2 analysis is a complex, high-level genetic sequencing test. It involves extracting your DNA, sequencing the entire genes, and having a geneticist analyze the data for any mutations. This advanced process at our laboratory takes time to ensure accuracy.